Publicação
Dissecting the effect of Parkinson’s Disease related PINK1 mutations on kinase activity
| Resumo: | Parkinson’s disease (PD), the second most common neurodegenerative movement disorder, affects approximately 2% of the population over 65. At present, there is only symptomatic but no causal cure for PD. Mitochondria are double membrane-bound organelles that are essential for energy production and cellular homeostasis in eukaryotic cells. Defects in this organelle are the underlying cause of several neurological disorders, namely PD. This mitochondrial connection has been furthered strengthened by the identification of mutations in the PINK1 gene that are linked to early-onset recessive PD. PINK1, a mitochondria targeted Ser/Thr kinase, regulates ATP production in healthy mitochondria by phosphorylating Complex I of the Electron Transport Chain. However, in damaged mitochondria PINK1 will phosphorylate Parkin and signal mitochondria for clearance via mitophagy. While understanding the regulation of PINK1 activity is pivotal to interpret how PINK1 executes its different functions in both healthy and damaged mitochondria it still remains unclear how PINK1 induced loss-of-function can affect the kinase activity and the overall (auto)phosphorylation status of PINK1. To scrutinize the impact that the PINK1 clinical mutation have on PINK1 function, we systematically analysed five PD-causing clinical mutations G309D, L347P, E417G, H271Q and W437X. In order access their ability to phosphorylate the known PINK1 substrate Parkin and to (auto)phosphorylate PINK1 an in vitro phosphorylation assay was implemented. To determine their effect towards Parkin recruitment and sequential induction of mitophagy an immunofluorescence techniques was used where staining against Parkin and a mitochondria reside protein was performed. Our results indicate that PINK1 is essential for Parkin recruitment, however the kinase activity is not required for this Parkin-mediated mitophagy pathway. |
|---|---|
| Autores principais: | Gonçalves, Filipa Alexandra Barroso |
| Assunto: | Mitochondria PINK1 Mitophagy Parkinson’s Disease |
| Ano: | 2016 |
| País: | Portugal |
| Tipo de documento: | dissertação de mestrado |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
Registos relacionados
article PINK1 : a bridge between mitochondria and Parkinson's disease
por: Gonçalves, Filipa
Publicado em: (2021)
por: Gonçalves, Filipa
Publicado em: (2021)
article Mitochondrial quality control pathways: PINK1 acts as a gatekeeper
por: Leites, Elvira
Publicado em: (2018)
por: Leites, Elvira
Publicado em: (2018)
article Transcription- and phosphorylation-dependent control of a functional interplay between XBP1s and PINK1 governs mitophagy and potentially impacts Parkinson disease pathophysiology
por: El Manaa, Wejdane
Publicado em: (2021)
por: El Manaa, Wejdane
Publicado em: (2021)
school The origin of pinking phenomenon of white wines: further insights into the pinking phenomenon
por: Gonçalves, Ana Carolina Rodrigues Lúcio
Publicado em: (2022)
por: Gonçalves, Ana Carolina Rodrigues Lúcio
Publicado em: (2022)
article Clinical pharmacology review of safinamide for the treatment of Parkinson’s disease
por: Fabbri, Margherita
Publicado em: (2015)
por: Fabbri, Margherita
Publicado em: (2015)
article RUFY4 exists as two translationally regulated isoforms, that localize to the mitochondrion in activated macrophages
por: Valečka, Jan
Publicado em: (2021)
por: Valečka, Jan
Publicado em: (2021)
article Parkinson’s Disease: Clinical Review and Update
por: Cabreira, Verónica
Publicado em: (2019)
por: Cabreira, Verónica
Publicado em: (2019)
article Opicapone for the treatment of Parkinson’s disease
por: Rodrigues, Filipe Brogueira
Publicado em: (2017)
por: Rodrigues, Filipe Brogueira
Publicado em: (2017)
article Substantia nigra neuromelanin as an imaging biomarker of disease progression in Parkinson’s disease
por: Fabbri, Margherita
Publicado em: (2017)
por: Fabbri, Margherita
Publicado em: (2017)
article Expectations of benefit in a trial of a candidate disease-modifying treatment for Parkinson disease
por: Mestre, Tiago
Publicado em: (2021)
por: Mestre, Tiago
Publicado em: (2021)
article Reliability and Validity of 39-Item Parkinson’s Disease Questionnaire and Parkinson’s Disease Quality of Life Questionnaire
por: Jesus-Ribeiro, Joana
Publicado em: (2017)
por: Jesus-Ribeiro, Joana
Publicado em: (2017)
article Moving towards integrated and personalized care in Parkinson's disease: a framework proposal for training Parkinson nurses
por: van Munster, Marlena
Publicado em: (2021)
por: van Munster, Marlena
Publicado em: (2021)
school Lipid alterations in Parkinson’s disease
por: Preciado, Laura Alexandre
Publicado em: (2023)
por: Preciado, Laura Alexandre
Publicado em: (2023)
article Dairy intake and Parkinson's disease: a Mendelian randomization study
por: Domenighetti, Cloé
Publicado em: (2022)
por: Domenighetti, Cloé
Publicado em: (2022)
article Frequency of dementia in Parkinson's disease: a systematic review and meta-analysis
por: Severiano e Sousa, Catarina
Publicado em: (2022)
por: Severiano e Sousa, Catarina
Publicado em: (2022)
school The extracellular role of DJ-1 in the regulation of signaling pathways: implications for Parkinson’s disease
por: Neves, Margarida Seco Martins Marques
Publicado em: (2021)
por: Neves, Margarida Seco Martins Marques
Publicado em: (2021)
article Effects of dual-task interventions on gait performance of patients with parkinson’s disease: a systematic review
por: Santos, Luís A. A.
Publicado em: (2016)
por: Santos, Luís A. A.
Publicado em: (2016)
article Dysphagia predicts poor outcome in late-stage Parkinson's disease
por: Fabbri, Margherita
Publicado em: (2019)
por: Fabbri, Margherita
Publicado em: (2019)
article Levodopa response in later stages of Parkinson's disease: a case-control study
por: Fabbri, Margherita
Publicado em: (2020)
por: Fabbri, Margherita
Publicado em: (2020)
article What is functional mobility applied to Parkinson’s disease?
por: Bouça-Machado, Raquel
Publicado em: (2018)
por: Bouça-Machado, Raquel
Publicado em: (2018)
school Role of cannabis in Parkinson's Disease therapy
por: Borges, Pedro Ramos
Publicado em: (2024)
por: Borges, Pedro Ramos
Publicado em: (2024)
article Opicapone to treat early wearing‐off in Parkinson's disease patients: the korean ADOPTION trial
por: Lee, Jee‐Young
Publicado em: (2024)
por: Lee, Jee‐Young
Publicado em: (2024)
article Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease
por: Martins, Madalena
Publicado em: (2011)
por: Martins, Madalena
Publicado em: (2011)
school Predicting the Outcome of Cognitive Training in Parkinson’s Disease using Magnetic Resonance Imaging
por: Maciel, Bernardo de Azevedo Pinto Castro
Publicado em: (2021)
por: Maciel, Bernardo de Azevedo Pinto Castro
Publicado em: (2021)
article Factors associated with self-rated health in people with late-stage parkinson’s and cognitive impairment
por: Pigott, Jennifer S.
Publicado em: (2024)
por: Pigott, Jennifer S.
Publicado em: (2024)
article Clinical pharmacology review of opicapone for the treatment of Parkinson's disease
por: Fabbri, Margherita
Publicado em: (2016)
por: Fabbri, Margherita
Publicado em: (2016)
rate_review Voice analysis in Parkinson's disease
por: Xavier, Daniela
Publicado em: (2025)
por: Xavier, Daniela
Publicado em: (2025)
school Distinguishing Parkinson’s Disease from other Parkinsonian disorders through a proteomics approach using PBMCs
por: Duarte, Diana Branco
Publicado em: (2023)
por: Duarte, Diana Branco
Publicado em: (2023)
school Unanswered Role of Cholesterol Homeostasis in Parkinson’s Disease
por: Caria, Inês de Sousa
Publicado em: (2020)
por: Caria, Inês de Sousa
Publicado em: (2020)
article Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease
por: Fabbri, M.
Publicado em: (2018)
por: Fabbri, M.
Publicado em: (2018)
article Hospital Mortality in Parkinson’s Disease: Retrospective Analysis in a Portuguese Tertiary Centre
por: Martins, Joana
Publicado em: (2016)
por: Martins, Joana
Publicado em: (2016)
article Patients and health professional's perspective of functional mobility in Parkinson's Disease
por: Bouça-Machado, Raquel
Publicado em: (2020)
por: Bouça-Machado, Raquel
Publicado em: (2020)
article Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease
por: Friedman, Joseph H.
Publicado em: (2010)
por: Friedman, Joseph H.
Publicado em: (2010)
article Cross-cultural adaptation and validation of the Swallowing Disturbance Questionnaire and the Sialorrhea Clinical Scale in Portuguese patients with Parkinson’s disease
por: Cardoso, Rita
Publicado em: (2020)
por: Cardoso, Rita
Publicado em: (2020)
school The transcriptional landscape of Alzheimer’s and Parkinson’s diseases
por: Bordone, Marie C.
Publicado em: (2021)
por: Bordone, Marie C.
Publicado em: (2021)
school Impact of GBA mutations in the outcomes of deep brain stimulation in Parkinson’s disease patients
por: Roque, Maria Marques
Publicado em: (2021)
por: Roque, Maria Marques
Publicado em: (2021)
school Study of the cell surface proteome for the analysis of Parkinson’s disease associated DJ-1 mutations
por: Jordão, Nuno Ricardo de Oliveira
Publicado em: (2015)
por: Jordão, Nuno Ricardo de Oliveira
Publicado em: (2015)
article Feasibility of a mobile-based system for unsupervised monitoring in Parkinson’s disease
por: Bouça-Machado, Raquel
Publicado em: (2021)
por: Bouça-Machado, Raquel
Publicado em: (2021)
school Multimodal response to levodopa treatment in advanced and late Parkinson’s disease
por: Fabbri, Margherita
Publicado em: (2019)
por: Fabbri, Margherita
Publicado em: (2019)
article Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease
por: Reimão, Sofia
Publicado em: (2015)
por: Reimão, Sofia
Publicado em: (2015)
Registos relacionados
-
article PINK1 : a bridge between mitochondria and Parkinson's disease
por: Gonçalves, Filipa
Publicado em: (2021) -
article Mitochondrial quality control pathways: PINK1 acts as a gatekeeper
por: Leites, Elvira
Publicado em: (2018) -
article Transcription- and phosphorylation-dependent control of a functional interplay between XBP1s and PINK1 governs mitophagy and potentially impacts Parkinson disease pathophysiology
por: El Manaa, Wejdane
Publicado em: (2021) -
school The origin of pinking phenomenon of white wines: further insights into the pinking phenomenon
por: Gonçalves, Ana Carolina Rodrigues Lúcio
Publicado em: (2022) -
article Clinical pharmacology review of safinamide for the treatment of Parkinson’s disease
por: Fabbri, Margherita
Publicado em: (2015)